Duration of shedding of Verocytotoxin-producing Escherichia coli in children and risk of transmission in childcare facilities in England

Epidemiology and Infection

Volumn 142, Issue 2, 2014, Pages 327-334

  Dabke, G ^a   Le Menach, A ^b,c   Black, A ^a   Gamblin, J ^a   Palmer, M ^a   Boxall, N ^b   Booth, L ^a  

^a Hampshire and Isle of Wight Health Protection Unit Wessex PHEC Unit 8   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

Carriage; child day care centres; disease outbreaks; England; shiga toxigenic Escherichia coli; transmission

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL SHEDDING; CHILD; DAY CARE; DESCRIPTIVE RESEARCH; DISEASE DURATION; DISEASE TRANSMISSION; ESCHERICHIA COLI INFECTION; FECES ANALYSIS; FEMALE; HUMAN; INFANT; MALE; MICROBIOLOGICAL EXAMINATION; NURSERY SCHOOL; RISK ASSESSMENT; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SHIGA TOXIN PRODUCING ESCHERICHIA COLI INFECTION; UNITED KINGDOM; ESCHERICHIA COLI INFECTIONS; MICROBIOLOGY; PRESCHOOL CHILD; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TIME; TRANSMISSION;

BACTERIAL SHEDDING; CHILD DAY CARE CENTERS; CHILD, PRESCHOOL; ENGLAND; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; RISK FACTORS; SHIGA-TOXIGENIC ESCHERICHIA COLI; TIME FACTORS;

EID: 84894377251     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026881300109X     Document Type: Article

References (37)

1. Health Protection Agency. Epidemiology of VTEC in England & Wales 2011. (http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/ EscherichiaColiO157/EpidemiologicalData/). Accessed 28 March 2013.
2. Gould LH, et al. Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006. Clinical Infectious Diseases 2009; 49: 1480-1485.
3. Tuttle J, et al. Lessons from a large outbreak of Escherichia coli O157:H7 infections: insights into the infectious dose and method of widespread contamination of hamburger patties. Epidemiology and Infection 1999; 122: 185-192.
4. Pennington H. Escherichia coli O157. Lancet 2010; 376: 1428-1435.
5. Roberts JA, Upton PA, Azene G. Escherichia coli O157: H7; an economic assessment of an outbreak. Journal of Public Health Medicine 2000; 22: 99-107.
6. Health Protection Agency. The VTEC operational manual 2011. Operational guidance for HPA staff dealing with cases and incidents of VTEC infection (http://www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1279889252950). Accessed 26 March 2013.
7. Health Protection Agency. HPZone update and award 2011. (http://www.hpa.org.uk/webc/HPAwebFile/HPAweb- C/1317131631173). Accessed 26 March 2013.
8. Health Protection Agency. Verocytotoxin-producing Escherichia coli. Enhanced surveillance questionnaire 2012. (http://www.hpa.org.uk/webc/ HPAwebFile/HPAweb- C/1229935272853). Accessed 28 March 2013.
9. Wells JG, et al. Laboratory investigation of hemorrha-gic colitis outbreaks associated with a rare Escherichia coli serotype. Journal of Clinical Microbiology 1983; 18: 512-520.
10. Belongia EA, et al. Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities. Journal of the American Medical Association 1993; 269: 883-888.
11. Wahl E, et al. Investigation of an Escherichia coli O145 outbreak in a child day-care centre-extensive sampling and characterization of eae-and stx1-positive E. coli yields epidemiological and socioeconomic insight. BMC Infectious Diseases 2011; 11: 238.
12. Miliwebsky E, et al. Prolonged fecal shedding of Shiga toxin-producing Escherichia coli among children attending day-care centers in Argentina. Revista Argentina de Microbiologia 2007; 39: 90-92.
13. Shah S, et al. Prolonged fecal shedding of Escherichia coli O157:H7 during an outbreak at a day care center. Clinical Infectious Diseases 1996; 23: 835-836.
14. Willshaw GA, et al. Verocytotoxin-producing Escher-ichia coli (VTEC) O157 and other VTEC from human infections in England and Wales: 1995-1998. Journal of Medical Microbiology 2001; 50: 135-142.
15. Jenkins C, et al. Assessment of a real-time PCR for the detection and characterization of verocytotoxigenic Escherichia coli. Journal of Medical Microbiology 2012; 61: 1082-1085.
16. Health Protection Agency. Investigation of faecal specimens for bacterial pathogens. National Standard Method, BSOP 30, Issue 7, 2010.
17. Karch H, et al. Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli O157 in diarrheal diseases. Journal of Clinical Microbiology 1995; 33: 1602-1605.
18. Brown JA, et al. Outbreak of shiga toxin-producing Escherichia coli serotype O26: H11 infection at a child care center in Colorado. Pediatric Infectious Disease Journal 2012; 31: 384-388.
19. Chapman PA, Wright DJ, Siddons CA. A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli O157 from bovine faeces. Journal of Medical Microbiology 1994; 40: 424-427.
20. Boyce TG, Swerdlow DL, Griffin PM. Escherichia coli O157:H7 and the hemolytic-uremic syndrome. New England Journal of Medicine 1995; 333: 364-368.
21. Pai CH, et al. Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study. Journal of Infectious Diseases 1988; 157: 1054-1057.
22. Wong CS, et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. New England Journal of Medicine 2000; 342: 1930-1936.
23. Pavia AT, et al. Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. Journal of Pediatrics 1990; 116: 544-551.
24. Ikeda K, et al. Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompan ying Escherichia coli O157:H7 infection. Clinical Nephrology 1999; 52: 357-362.
25. Proulx F, et al. Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. Journal of Pediatrics 1992; 121: 299-303.
26. Safdar N, et al. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. Journal of the American Medical Association 2002; 288: 996-1001.
27. Nitschke M, et al. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. Journal of the American Medical Association 2012; 307: 1046-1052.
28. Seifert ME, Tarr PI. Therapy: azithromycin and decolonization after HUS. Nature Reviews Nephrology 2012; 8: 317-318.
29. Snedeker KG, et al. Primary and secondary cases in Escherichia coli O157 outbreaks: a statistical analysis. BMC Infectious Diseases 2009; 9: 144.
30. Parry SM, Salmon RL. Sporadic STEC O157 infection: secondary household transmission in Wales. Emerging Infectious Diseases 1998; 4: 657-661.
31. Al-Jader L, et al. Outbreak of Escherichia coli O157 in a nursery: lessons for prevention. Archives of Disease in Childhood 1999; 81: 60-63.
32. Lerman Y, et al. A cluster of cases of Escherichia coli O157 infection in a day-care center in a communal settlement (Kibbutz) in Israel. Journal of Clinical Microbiology 1992; 30: 520-521.
33. Reida P, et al. An outbreak due to enterohaemor-rhagic Escherichia coli O157:H7 in a children day care centre characterized by person-to-person transmission and environmental contamination. Zentralblatt fur Bak-teriologie 1994; 281: 534-543.
34. Gilbert M, et al. Screening policies for daycare attendees: lessons learned from an outbreak of E. coli O157:H7 in a daycare in Waterloo, Ontario. Canadian Journal of Public Health 2008; 99: 281-285.
35. Tam CC, et al. Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut 2012; 61: 69-77.
36. Vogelsang E, Pulz M. Environmental studies of asymptomatic kindergarten children as carriers of enterohemorrhagic Escherichia coli (EHEC) in the Ammerland district [in German]. Gesundheitswesen 1999; 61: 38-44.
37. Swerdlow DL, Griffin PM. Duration of faecal shedding of Escherichia coli O157:H7 among children in day-care centres. Lancet 1997; 349: 745-746.